CARIPORIDE

CARIPORIDE

Catalog Number:
L002371313APE
Mfr. No.:
APE-B5895
Price:
$180
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          Description:IC50: 0.05, 3 and 1000 μM for NHE1, NHE3 and NHE2, respectivelyNa–H exchange (NHE) represents an important mechanism for mediating such injury. NHE represents an important mechanism for the development of myocardial ischemic and reperfusion injury and inhibitors have been consistently shown to protect the ischemic and reperfused heart by correcting the ionic imbalance associated with this form of pathological insult. Cariporide is a potent NHE inhibitor.In vitro: Cariporide concentration dependently inhibited the amiloride sensitive sodium influx in rabbit erythrocytes, reduced the swelling of human platelets caused by intracellular acidification, and delayed pH recovery in rat cardiomyocytes [1]. In vivo: In anaesthetised rats undergoing coronary artery ligation intravenous and oral pretreatment with Cariporide caused a dose dependent reduction or a complete prevention of ventricular premature beats, ventricular fibrillation, and ventricular tachycardia. The compound was well tolerated and neutral to circulatory variables [1]. Clinical trial: Cariporide has been evaluated in a large dose-finding Phase II/Phase III clinical trial to assess the efficacy in patients with acute coronary syndromes. Overall results failed to demonstrate protection but sub-group analysis revealed significant risk reductions with the highest cariporide dose especially in high risk patients undergoing coronary artery bypass surgery [2].

          [1] Scholz W, Albus U, Counillon L, G?gelein H, Lang HJ, Linz W, Weichert A, Sch?lkens BA. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res. 1995 Feb;29(2):260-8.
          [2] Karmazyn M. Pharmacology and clinical assessment of cariporide for the treatment coronary artery diseases. Expert Opin Investig Drugs. 2000 May;9(5):1099-108.

      • Properties
        • Alternative Name
          (Z)-N-carbamimidoyl-4-isopropyl-3-(methylsulfonyl)benzimidic acid
          CAS Number
          159138-80-4
          Molecular Formula
          C12H17N3O3S
          Molecular Weight
          283.35
          Appearance
          A solid
          Purity
          99.69%
          Solubility
          insoluble in H2O; ≥12.05 mg/mL in DMSO; ≥2.675 mg/mL in EtOH with gentle warming and ultrasonic
          Storage
          Store at -20°C

          * For Research Use Only

    We Also Recommend

    K-7174

    $276

    ML352

    $294

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.